| Year |
Citation |
Score |
| 2024 |
Appelbaum J, Price AE, Oda K, Zhang J, Leung WH, Tampella G, Xia D, So PP, Hilton SK, Evandy C, Sarkar S, Martin U, Krostag AR, Leonardi M, Zak DE, ... ... Hollands A, et al. Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing. The Journal of Clinical Investigation. PMID 38502193 DOI: 10.1172/JCI162593 |
0.716 |
|
| 2017 |
Andreoni F, Ugolini F, Keller N, Neff A, Nizet V, Hollands A, Marques Maggio E, Zinkernagel AS, Schuepbach RA. Immunoglobulin attenuates streptokinase-mediated virulence in Streptococcus dysgalactiae subsp. equisimilis necrotizing fasciitis. The Journal of Infectious Diseases. PMID 29099935 DOI: 10.1093/Infdis/Jix560 |
0.67 |
|
| 2017 |
Guichard A, Jain P, Moayeri M, Schwartz R, Chin S, Zhu L, Cruz-Moreno B, Liu JZ, Aguilar B, Hollands A, Leppla SH, Nizet V, Bier E. Anthrax edema toxin disrupts distinct steps in Rab11-dependent junctional transport. Plos Pathogens. 13: e1006603. PMID 28945820 DOI: 10.1371/Journal.Ppat.1006603 |
0.767 |
|
| 2016 |
Hollands A, Corriden R, Gysler G, Dahesh S, Olson J, Ali SR, Kunkel MT, Lin AE, Forli S, Newton AC, Kumar GB, Nair BG, Perry JJ, Nizet V. Natural product anacardic acid from cashew nut shells stimulates neutrophil extracellular trap production and bactericidal activity. The Journal of Biological Chemistry. PMID 27226531 DOI: 10.1074/Jbc.M115.695866 |
0.704 |
|
| 2015 |
Corriden R, Hollands A, Olson J, Derieux J, Lopez J, Chang JT, Gonzalez DJ, Nizet V. Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide. Nature Communications. 6: 8369. PMID 26458291 DOI: 10.1038/Ncomms9369 |
0.779 |
|
| 2015 |
Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, Kumaraswamy M, Rivera H, Corriden R, Rohde M, Hensler ME, Burkart MD, Pogliano J, Sakoulas G, Nizet V. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. Ebiomedicine. 2: 690-8. PMID 26288841 DOI: 10.1016/J.Ebiom.2015.05.021 |
0.779 |
|
| 2015 |
Lin AE, Beasley FC, Keller N, Hollands A, Urbano R, Troemel ER, Hoffman HM, Nizet V. A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response. Mbio. 6: e00133. PMID 25759502 DOI: 10.1128/Mbio.00133-15 |
0.789 |
|
| 2015 |
Patel V, Carrion K, Hollands A, Hinton A, Gallegos T, Dyo J, Sasik R, Leire E, Hardiman G, Mohamed SA, Nigam S, King CC, Nizet V, Nigam V. The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-κB signaling, and inflammatory gene expression in human aortic valve cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1859-68. PMID 25630970 DOI: 10.1096/Fj.14-257808 |
0.737 |
|
| 2015 |
Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, Kumaraswamy M, Rivera H, Corriden R, Rohde M, Hensler ME, Burkart MD, Pogliano J, Sakoulas G, Nizet V. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens Ebiomedicine. DOI: 10.1016/j.ebiom.2015.05.021 |
0.774 |
|
| 2014 |
Franks SE, Ebrahimi C, Hollands A, Okumura CY, Aroian RV, Nizet V, McGillivray SM. Novel role for the yceGH tellurite resistance genes in the pathogenesis of Bacillus anthracis. Infection and Immunity. 82: 1132-40. PMID 24366250 DOI: 10.1128/Iai.01614-13 |
0.786 |
|
| 2013 |
Leire E, Olson J, Isaacs H, Nizet V, Hollands A. Role of hypoxia inducible factor-1 in keratinocyte inflammatory response and neutrophil recruitment. Journal of Inflammation (London, England). 10: 28. PMID 23937964 DOI: 10.1186/1476-9255-10-28 |
0.759 |
|
| 2013 |
Sjögren J, Struwe WB, Cosgrave EF, Rudd PM, Stervander M, Allhorn M, Hollands A, Nizet V, Collin M. EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein. The Biochemical Journal. 455: 107-18. PMID 23865566 DOI: 10.1042/Bj20130126 |
0.771 |
|
| 2013 |
Sanderson-Smith ML, Zhang Y, Ly D, Donahue D, Hollands A, Nizet V, Ranson M, Ploplis VA, Walker MJ, Castellino FJ. A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. Plos Pathogens. 9: e1003469. PMID 23853591 DOI: 10.1371/Journal.Ppat.1003469 |
0.574 |
|
| 2013 |
Tsatsaronis JA, Hollands A, Cole JN, Maamary PG, Gillen CM, Ben Zakour NL, Kotb M, Nizet V, Beatson SA, Walker MJ, Sanderson-Smith ML. Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2633-43. PMID 23531597 DOI: 10.1096/Fj.12-226662 |
0.719 |
|
| 2012 |
Hollands A, Gonzalez D, Leire E, Donald C, Gallo RL, Sanderson-Smith M, Dorrestein PC, Nizet V. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides. The Journal of Biological Chemistry. 287: 40891-7. PMID 23038245 DOI: 10.1074/Jbc.M112.404582 |
0.797 |
|
| 2012 |
Maamary PG, Ben Zakour NL, Cole JN, Hollands A, Aziz RK, Barnett TC, Cork AJ, Henningham A, Sanderson-Smith M, McArthur JD, Venturini C, Gillen CM, Kirk JK, Johnson DR, Taylor WL, et al. Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4675-84. PMID 22878963 DOI: 10.1096/Fj.12-212142 |
0.686 |
|
| 2012 |
Gonzalez DJ, Okumura CY, Hollands A, Kersten R, Akong-Moore K, Pence MA, Malone CL, Derieux J, Moore BS, Horswill AR, Dixon JE, Dorrestein PC, Nizet V. Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. The Journal of Biological Chemistry. 287: 13889-98. PMID 22371493 DOI: 10.1074/Jbc.M112.349860 |
0.755 |
|
| 2012 |
Okumura CY, Hollands A, Tran DN, Olson J, Dahesh S, von Köckritz-Blickwede M, Thienphrapa W, Corle C, Jeung SN, Kotsakis A, Shalwitz RA, Johnson RS, Nizet V. A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection. Journal of Molecular Medicine (Berlin, Germany). 90: 1079-89. PMID 22371073 DOI: 10.1007/S00109-012-0882-3 |
0.8 |
|
| 2011 |
Gonzalez DJ, Haste NM, Hollands A, Fleming TC, Hamby M, Pogliano K, Nizet V, Dorrestein PC. Microbial competition between Bacillus subtilis and Staphylococcus aureus monitored by imaging mass spectrometry. Microbiology (Reading, England). 157: 2485-92. PMID 21719540 DOI: 10.1099/Mic.0.048736-0 |
0.764 |
|
| 2011 |
Sjögren J, Okumura CY, Collin M, Nizet V, Hollands A. Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence Bmc Microbiology. 11. PMID 21619648 DOI: 10.1186/1471-2180-11-120 |
0.796 |
|
| 2010 |
Cole JN, Pence MA, von Köckritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. Mbio. 1. PMID 20827373 DOI: 10.1128/Mbio.00191-10 |
0.806 |
|
| 2010 |
Pence MA, Rooijakkers SH, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V. Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. Journal of Innate Immunity. 2: 587-95. PMID 20814187 DOI: 10.1159/000317672 |
0.803 |
|
| 2010 |
Maamary PG, Sanderson-Smith ML, Aziz RK, Hollands A, Cole JN, McKay FC, McArthur JD, Kirk JK, Cork AJ, Keefe RJ, Kansal RG, Sun H, Taylor WL, Chhatwal GS, Ginsburg D, et al. Parameters governing invasive disease propensity of non-M1 serotype group A streptococci. Journal of Innate Immunity. 2: 596-606. PMID 20814186 DOI: 10.1159/000317640 |
0.687 |
|
| 2010 |
Hollands A, Pence MA, Timmer AM, Osvath SR, Turnbull L, Whitchurch CB, Walker MJ, Nizet V. Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. The Journal of Infectious Diseases. 202: 11-9. PMID 20507231 DOI: 10.1086/653124 |
0.755 |
|
| 2010 |
Berends ETM, Horswill AR, Haste NM, Monestier M, Nizet V, Köckritz-Blickwede Mv, Hertzén E, Johansson L, Wallin R, Schmidt H, Kroll M, Rehn AP, Kotb M, Mörgelin M, Norrby-Teglund A, ... ... Hollands A, et al. Contents Vol. 2, 2010 Journal of Innate Immunity. 2. DOI: 10.1159/000321132 |
0.72 |
|
| 2010 |
Berends ETM, Horswill AR, Haste NM, Monestier M, Nizet V, Köckritz-Blickwede Mv, Hertzén E, Johansson L, Wallin R, Schmidt H, Kroll M, Rehn AP, Kotb M, Mörgelin M, Norrby-Teglund A, ... ... Hollands A, et al. Subject Index Vol. 2, 2010 Journal of Innate Immunity. 2: 627-628. DOI: 10.1159/000321131 |
0.726 |
|
| 2008 |
Hollands A, Aziz RK, Kansal R, Kotb M, Nizet V, Walker MJ. A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. Plos One. 3: e4102. PMID 19116661 DOI: 10.1371/Journal.Pone.0004102 |
0.532 |
|
| 2007 |
Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, Simpson AJ, Buchanan JT, Chhatwal GS, Kotb M, Nizet V. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nature Medicine. 13: 981-5. PMID 17632528 DOI: 10.1038/Nm1612 |
0.774 |
|
| Show low-probability matches. |